ASH insider filings
ASHLAND INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-18. Screen ASH transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 20 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 54.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
+1 more insider in the window, not shown — every filing appears in the table below.
Recent insider filings — ASHLAND INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | Drury Eileen — SVP and Chief HRO | Option exercise (M): 1,332 @ $75.57 · Tax withholding (F): 657 @ $75.57 · Option exercise (M): 1,332 (derivative) @ $0 | EDGAR |
| 2026-11-18 | 4 | NOVO GUILLERMO — Chair of the Board and CEO, Director | Option exercise (M): 9,366 @ $75.57 · Tax withholding (F): 3,920 @ $75.57 · Option exercise (M): 9,366 (derivative) @ $0 | EDGAR |
| 2026-11-18 | 4 | MUSA OSAMA M — SVP and CTO | Option exercise (M): 2,147 @ $75.57 · Tax withholding (F): 1,099 @ $75.57 · Option exercise (M): 2,147 (derivative) @ $0 | EDGAR |
| 2026-11-18 | 4 | WHITAKER WILLIAM — SVP, CFO & PFO | Option exercise (M): 367 @ $75.57 · Tax withholding (F): 109 @ $75.57 · Option exercise (M): 367 (derivative) @ $0 | EDGAR |
| 2026-11-18 | 4 | MINICUCCI JAMES P. — SVP and GM, Personal Care | Option exercise (M): 1,259 @ $75.57 · Tax withholding (F): 395 @ $75.57 · Option exercise (M): 1,259 (derivative) @ $0 | EDGAR |
| 2026-11-18 | 4 | LAMPKIN ROBIN E. — SVP, GC & Secretary | Option exercise (M): 1,310 @ $75.57 · Tax withholding (F): 382 @ $75.57 · Option exercise (M): 1,310 (derivative) @ $0 | EDGAR |
| 2026-11-18 | 4 | RICHARDSON SAMUEL — VP, Controller and PAO | Option exercise (M): 235 @ $75.57 · Tax withholding (F): 69 @ $75.57 · Option exercise (M): 235 (derivative) @ $0 | EDGAR |
| 2026-11-17 | 4 | Caceres Dago — SVP & GM, Specialty Additives | Option exercise (M): 767 @ $76.47 · Tax withholding (F): 221 @ $76.47 · Option exercise (M): 767 (derivative) @ $0 | EDGAR |
| 2026-11-17 | 4 | MINICUCCI JAMES P. — SVP and GM, Personal Care | Option exercise (M): 1,048 @ $76.47 · Tax withholding (F): 328 @ $76.47 · Option exercise (M): 1,048 (derivative) @ $0 | EDGAR |
| 2026-11-17 | 4 | NOVO GUILLERMO — Chair of the Board and CEO, Director | Option exercise (M): 9,273 @ $76.47 · Tax withholding (F): 3,881 @ $76.47 · Option exercise (M): 9,273 (derivative) @ $0 | EDGAR |
| 2026-11-17 | 4 | MUSA OSAMA M — SVP and CTO | Option exercise (M): 1,431 @ $76.47 · Tax withholding (F): 686 @ $76.47 · Option exercise (M): 1,431 (derivative) @ $0 | EDGAR |
| 2026-11-17 | 4 | LAMPKIN ROBIN E. — SVP, GC & Secretary | Option exercise (M): 890 @ $76.47 · Tax withholding (F): 259 @ $76.47 · Option exercise (M): 890 (derivative) @ $0 | EDGAR |
| 2026-11-17 | 4 | RICHARDSON SAMUEL — VP, Controller and PAO | Option exercise (M): 151 @ $76.47 · Tax withholding (F): 44 @ $76.47 · Option exercise (M): 151 (derivative) @ $0 | EDGAR |
| 2026-11-17 | 4 | Drury Eileen — SVP and Chief HRO | Option exercise (M): 888 @ $76.47 · Tax withholding (F): 412 @ $76.47 · Option exercise (M): 888 (derivative) @ $0 | EDGAR |
| 2026-11-17 | 4 | WHITAKER WILLIAM — SVP, CFO & PFO | Option exercise (M): 236 @ $76.47 · Tax withholding (F): 70 @ $76.47 · Option exercise (M): 236 (derivative) @ $0 | EDGAR |
| 2026-11-17 | 4 | Assis Alessandra Faccin — SVP and GM, Life Sciences | Option exercise (M): 1,376 @ $76.47 · Tax withholding (F): 586 @ $76.47 · Option exercise (M): 1,376 (derivative) @ $0 | EDGAR |
| 2026-10-01 | 4 | Chattopadhyay Sanat — Director | Grant/award (A): 212 (derivative) @ $67.92 | EDGAR |
| 2026-10-01 | 4 | Bishop Steven D — Director | Grant/award (A): 368 (derivative) @ $67.92 | EDGAR |
| 2026-09-23 | 4 | MUSA OSAMA M — SVP and CTO | Option exercise (M): 10,418 @ $69.06 · Tax withholding (F): 3,647 @ $69.06 · Option exercise (M): 10,418 (derivative) @ $0 | EDGAR |
| 2026-09-16 | 4 | MUSA OSAMA M — SVP and CTO | Grant/award (A): 14,230 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | LAMPKIN ROBIN E. — SVP, GC & Secretary | Option exercise (M): 1,806 @ $74.58 · Tax withholding (F): 526 @ $74.58 · Option exercise (M): 1,806 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | SPIZZO ALLEN A — Director | Grant/award (A): 978 (derivative) @ $66.38 | EDGAR |
| 2026-08-05 | 4 | Thomas Peter T — Director | Grant/award (A): 978 (derivative) @ $66.38 | EDGAR |
| 2026-07-30 | 4 | MUSA OSAMA M — SVP and CTO | Option exercise (M): 1,267 @ $57.96 · Option exercise (M): 9,793 (derivative) @ $0 | EDGAR |
| 2026-07-29 | 4 | Assis Alessandra Faccin — SVP and GM, Life Sciences | Option exercise (M): 3,215 @ $66.38 · Tax withholding (F): 884 @ $66.38 · Option exercise (M): 3,215 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Chattopadhyay Sanat — Director | Grant/award (A): 218 (derivative) @ $65.89 | EDGAR |
| 2026-07-01 | 4 | Bishop Steven D — Director | Grant/award (A): 379 (derivative) @ $65.89 | EDGAR |
| 2026-05-18 | 4 | LOY BERTRAND — Director | Grant/award (A): 1,741 (derivative) @ $54.50 | EDGAR |
| 2026-05-11 | 4 | MINICUCCI JAMES P. — SVP and GM, Personal Care | Option exercise (M): 4,310 @ $55.01 · Tax withholding (F): 1,346 @ $55.01 · Option exercise (M): 4,310 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Chattopadhyay Sanat — Director | Grant/award (A): 258 (derivative) @ $55.61 | EDGAR |
| 2026-04-01 | 4 | Bishop Steven D — Director | Grant/award (A): 450 (derivative) @ $55.61 | EDGAR |
| 2026-02-10 | 4 | NOVO GUILLERMO — Chair of the Board and CEO, Director | Grant/award (A): 32,096 (derivative) @ $0 | EDGAR |
| 2026-01-22 | 4 | Harrison Suzan F. — Director | Grant/award (A): 2,449 (derivative) @ $61.23 | EDGAR |
| 2026-01-22 | 4 | Kulkarni Ashish K — Director | Option exercise (M): 2,113 @ $0 · Grant/award (A): 2,449 (derivative) @ $61.23 · Option exercise (M): 2,113 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Chattopadhyay Sanat — Director | Grant/award (A): 2,449 (derivative) @ $61.23 | EDGAR |
| 2026-01-21 | 4 | Bishop Steven D — Director | Grant/award (A): 2,449 (derivative) @ $61.23 | EDGAR |
| 2026-01-21 | 4 | Tozier Scott — Director | Grant/award (A): 2,449 (derivative) @ $61.23 | EDGAR |
| 2026-01-21 | 4 | Peribere Jerome A — Director | Grant/award (A): 2,449 (derivative) @ $61.23 | EDGAR |
| 2026-01-21 | 4 | MAIN SUE — Director | Grant/award (A): 2,449 (derivative) @ $61.23 | EDGAR |
| 2026-01-05 | 4 | Chattopadhyay Sanat — Director | Grant/award (A): 245 (derivative) @ $58.67 | EDGAR |
| 2026-01-05 | 4 | Bishop Steven D — Director | Grant/award (A): 426 (derivative) @ $58.67 | EDGAR |
| 2025-11-21 | 4 | Assis Alessandra Faccin — SVP and GM, Life Sciences | Grant/award (A): 6,136 (derivative) @ $0 · Grant/award (A): 13,807 (derivative) @ $0 | EDGAR |
| 2025-11-21 | 4 | LAMPKIN ROBIN E. — SVP, Gen Counsel and Secrty. | Grant/award (A): 3,965 (derivative) @ $0 · Grant/award (A): 8,922 (derivative) @ $0 | EDGAR |
| 2025-11-21 | 4 | WHITAKER WILLIAM — SVP, CFO & PFO | Grant/award (A): 10,280 (derivative) @ $0 · Grant/award (A): 23,131 (derivative) @ $0 | EDGAR |
| 2025-11-21 | 4 | MUSA OSAMA M — SVP and CTO | Grant/award (A): 6,379 (derivative) @ $0 · Grant/award (A): 14,354 (derivative) @ $0 | EDGAR |
| 2025-11-21 | 4 | MINICUCCI JAMES P. — SVP and GM, Personal Care | Grant/award (A): 5,049 (derivative) @ $0 · Grant/award (A): 11,361 (derivative) @ $0 | EDGAR |
| 2025-11-21 | 4 | Caceres Dago — SVP & GM, Specialty Additives | Grant/award (A): 4,250 (derivative) @ $0 · Grant/award (A): 9,564 (derivative) @ $0 | EDGAR |
| 2025-11-21 | 4 | Drury Eileen — SVP and Chief HRO | Grant/award (A): 3,954 (derivative) @ $0 · Grant/award (A): 8,897 (derivative) @ $0 | EDGAR |
| 2025-11-21 | 4 | RICHARDSON SAMUEL — VP, Controller and PAO | Grant/award (A): 1,738 (derivative) @ $0 · Grant/award (A): 3,912 (derivative) @ $0 | EDGAR |
| 2025-11-21 | 4 | NOVO GUILLERMO — Chair of the Board and CEO, Director | Grant/award (A): 43,495 (derivative) @ $0 · Grant/award (A): 97,864 (derivative) @ $0 | EDGAR |
Recent 8-K events — ASHLAND INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-03 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-25 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-07-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-28 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-05-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-28 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-02 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
GET https://api.filingpulse.io/v1/insider-trades?ticker=ASH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs